Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Precipio Inc

PRPO ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: N/A

Last Close

$23.50

▲ +1.25%

Market Cap $42.00M · Vol 35.20K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$42.00M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

53.96

Momentum

Beta

1.33

vs Market

52W High

$33.50

29.85% below

52W Low

$14.00

67.86% above

Volume

35.20K

Avg 39.13K

P/B

2.81

Price-to-book

ROE

N/A

Return on equity

Free Float

87.35%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Precipio Inc (PRPO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PRPO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.96%

+1.29%

-17.83%

+0.47%

YTD

+2.26%

+59.76%

+227.30%

-61.60%

Financials & Valuation

TTM · Annual

Total Revenue	$24.05M
Net Income	$-363,000.00
Revenue Growth (YoY)	+148.36%
Gross Margin	44.52%
Operating Margin	-5.00%
Net Profit Margin	-1.51%
ROE	N/A
ROA · ROIC	-1.89% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.53
P/B	2.81
P/FCF	102.74
EPS Growth	N/A
Outstanding Shares	1.79M

Technical Indicators

50-Day SMA	$23.39
200-Day SMA	$24.55
RSI (14)	53.96
Beta	1.33
52-Week High	$33.50
52-Week Low	$14.00

Volume Today	35.20K
Avg Daily Volume (30D)	39.13K
Relative Volume	0.90x
Volatility (10D)	40.94
Volatility (30D)	59.85
Free Float	87.35%

Analyst Consensus

N/A

Current Price $23.50

Mean Target N/A

52W Low$14.00 52W High$33.50

Current

Target

$14.00 $33.50

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SF2K06

ISINUS74019L6020

CountryUnited States of America

Sub-IndustryMedical Diagnostic & Testing Equipment

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SRT.DE Sartorius AG -1.14% BIOT.ST Biotage AB +0.14% EUZ.DE Eckert & Ziegler SE -0.44% VREX Varex Imaging Corp -0.05% REG1V.HE Revenio Group Oyj +5.89%

Company Profile

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.